BuyRetaUK buyRetaUK sells GLP-1 compounds (retatrutide, tirzepatide, semaglutide) and says 'every batch is independently tested by third-party labs via HPLC and mass spectrometry,' but names no laboratory and offers no certificate you can verify. The domain was registered on 16 June 2026, only weeks ago, and the trading company, Oxford Research Syndicate Ltd (Companies House 17207898), gives a Barking, Essex address that has nothing to do with the 'Oxford' branding. A brand-new shop moving patented GLP-1 medicines behind an unverifiable testing claim warrants real caution. Its cited company number 17207898 is Oxford Research Syndicate Ltd (formerly Prapen Group Limited, renamed twice within seven weeks), registered under a management-consultancy SIC code.
See the full audit. This is the short answer; the full BuyRetaUK dossier has the certificate check with a live verification link, the Companies House record, pricing against the market and the complete checklist.
BuyRetaUK (buyretauk.com) is on The Peptide Watch's watch list. It does not publish a certificate of analysis that can be independently verified in its own name, so its quality claims rest on trust rather than checkable evidence. That is not proof of a scam; it means the evidence does not check out.
You cannot independently verify its testing today. A good delivery reputation is not the same as a verifiable certificate; the two are unrelated. Until BuyRetaUK publishes an own-name certificate you can check on an independent lab's website, you are taking its quality on trust.
The Peptide Watch does not assert that. What is observable is the reason it sits on the watch list: no named lab, nothing to verify. Being unverifiable is a reason for caution, not proof of fraud.
Not one that can be independently verified in its own name. ⚠ Brand-new GLP-1 shop, no lab named. BuyRetaUK sells retatrutide, tirzepatide and semaglutide from a domain registered weeks ago, claiming 'third-party lab' testing but naming no lab and publishing no verifiable certifi